Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, B-Cell

Explore clinical trials studying Lymphoma, B-Cell. Study availability and eligibility vary by location and protocol.

1,618 public trials 340 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, B-Cell trial results

Recruiting

Effectiveness and Safety of Tisagenlecleucel Therapy in Brazilian Patients With B-lymphocyte Malignancies

NCT05541341

Conditions
Acute Lymphoblastic Leukemia, Diffuse Large B-cell Lymphoma, Follicular Lymphoma, +16 more
Locations
  • Novartis Investigative Site Minas Gerais, Belo Horizonte, Brazil
  • Novartis Investigative Site Salvador, Estado de Bahia, Brazil
  • Novartis Investigative Site Curitiba, Paraná, Brazil
  • Novartis Investigative Site São Paulo, Brazil
View Trial Details
Recruiting

Vaccination Against Human Papillomavirus (HPV) After Allogeneic Stem Cell Transplantation

NCT06793410

Conditions
Acute Myeloid Leukaemia, Bone Marrow Diseases, Communicable Diseases, +32 more
Locations
  • Skåne's University Hospital Lund, Region Skåne, Sweden
  • Karolinska University Hospital Stockholm, Region Stockholm, Sweden
  • Uppsala University Hospital Uppsala, Region Uppsala, Sweden
  • Linköping University Hospital Linköping, Region Östergötaland, Sweden
View Trial Details
Recruiting

A Clinical Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of B019 Injection in Subjects With Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia.

NCT06927466

Conditions
Burkitt Lymphoma, DNA Virus Infections, Disease Attributes, +19 more
Locations
  • Peking University People's Hospital Beijing, China
  • Jiangxi Province pediatric hospital Nanchang, China
  • The First Affiliated Hospital of Nanchang University Nanchang, China
  • Children's Hospital of Shanghai Shanghai, China
View Trial Details
Recruiting

Phase 1/2 Study of CD19 Chimeric Antigen Receptor T-cell (CD19 CAR-T; PL001) for Relapsed or Refractory B-cell Lymphoma

NCT05326243

Conditions
Diffuse Large B Cell Lymphoma, Follicular Lymphoma Grade 3A, Follicular Lymphoma Grade 3B, +13 more
Locations
  • National Taiwan University Hospital Taipei, Taiwan
  • Kaohsiung Medical University Chung-Ho Memorial Hospital Kaohsiung City, Taiwan
  • Chi Mei Medical Center Tainan, Taiwan
  • Taipei Medical University - Taipei Medical University Hospital Taipei, Taiwan
View Trial Details
Recruiting

Long-term Follow-up Study of Lentiviral-based Gene-edited Immune Cell Therapy

NCT05377307

Conditions
Dendritic Cell Sarcoma, Interdigitating, Diffuse Large B Cell Lymphoma, Follicular Lymphoma Grade 3A, +16 more
Locations
  • Kaohsiung Medical University Chung-Ho Memorial Hospital Kaohsiung, Taiwan
  • National Taiwan University Hospital Taipei, Taiwan
  • Taipei Veterans General Hospital Taipei, Taiwan
  • Chi Mei Medical Center Tainan, Taiwan
View Trial Details
Recruiting

The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL

NCT03509961

Conditions
B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, DNA Virus Infections, +15 more
Locations
  • Children's of Alabama/University of Alabama in Birmingham(UAB) Birmingham, Alabama, United States
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • City of Hope Duarte, California, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
View all 24 locations
View Trial Details
Recruiting

A Phase 1/2 Study of IDP-121 in Patients With Relapsed/Refractory Hematologic Malignancies

NCT05908409

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +31 more
Locations
  • Hospital Universitario Marques de Valdecilla Santander, Cantabria, Spain
  • Hospital Universitario de Salamanca Salamanca, Castille and León, Spain
  • Hospital Universitari Vall d'hebron Barcelona, Spain
  • Hospital Durán i Reynals - ICO L´Hospitalet Barcelona, Spain
View Trial Details

Related conditions